← Leaderboards
Li Mao
Baylor College Of Medicine
$5,442,218
Attributed
$5,442,218
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $692.5K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,442,218 · 7
By mechanism
R01$3,139,840 · 2
P01$1,919,938 · 3
R21$333,862 · 1
P30$48,578 · 1
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Francesco John Demayo$23,405,197
- Yanhong Liu$1,485,083
- David John Tweardy$14,168,425
Others in their field
Top investigators on “Molecular Profiling”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- Larry Arthur$120,372,162
- Ed Lein · Allen Institute$92,863,470
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
- Myron S Cohen · Family Health International$91,263,426
- David Heimbrook · Leidos Biomedical Research, Inc.$71,770,742
Research focus
Molecular ProfilingCancer EtiologyTumorUnited StatesWomanCessation Of LifeBiologicalCancer Cell LineTherapeutic EffectMalignant NeoplasmsEpithelialAnimalsEpithelial CellsMalignant Neoplasm Of LungResponseNon-Small-Cell Lung CarcinomaCancer TherapyBaseCancer PreventionTumor Suppressor GenesAntibodiesHead And Neck StructureCancer CellInhibitor/Antagonist
Grant awards (24)
Experimental Therapeutics (ET)$48,578
P30 · FY2017 · CA · contact PI
Early detection of breast cancer serum antigens with lambodies$166,931
R21 · FY2015 · CA · contact PI
Early detection of breast cancer serum antigens with lambodies$166,931
R21 · FY2014 · CA · contact PI
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS$157,870
R01 · FY2014 · CA · contact PI
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS$121,045
R01 · FY2013 · CA · contact PI
HDGF: a novel biomarker and therapetic target of lung cancer$390,636
R01 · FY2012 · CA · contact PI
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS$301,913
R01 · FY2012 · CA · contact PI
HDGF: a novel biomarker and therapetic target of lung cancer$301,913
R01 · FY2011 · CA · contact PI
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS$301,913
R01 · FY2011 · CA · contact PI
HDGF: a novel biomarker and therapetic target of lung cancer$311,250
R01 · FY2010 · CA · contact PI
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS$311,250
R01 · FY2010 · CA · contact PI
HDGF: a novel biomarker and therapetic target of lung cancer$311,250
R01 · FY2009 · CA · contact PI
ROLE OF DNA METHYLTRANSFERASE 3B IN LUNG TUMORIGENESIS$311,250
R01 · FY2009 · CA · contact PI
HDGF: a novel biomarker and therapetic target of lung cancer$319,550
R01 · FY2008 · CA · contact PI
MOLECULAR DEFECTS IN ORAL CARCINOGENESIS$131,246
P01 · FY2008 · CA · contact PI
MOLECULAR DEFECTS IN ORAL CARCINOGENESIS$300,500
P01 · FY2007 · CA · contact PI
MOLECULAR DEFECTS IN ORAL CARCINOGENESIS$219,914
P01 · FY2006 · CA · contact PI
MOLECULAR DEFECTS IN ORAL CARCINOGENESIS$213,976
P01 · FY2005 · CA
MOLECULAR DEFECTS IN ORAL CARCINOGENESIS$207,913
P01 · FY2004 · CA
MOLECULAR ALTERATIONS IN LUNG CARCINOGENESIS$0
P01 · FY2002 · CA
CORE--TUMOR BIOLOGY$296,752
P01 · FY2001 · CA
CORE--TUMOR BIOLOGY$296,752
P01 · FY2001 · CA
MOLECULAR ALTERATIONS IN LUNG CARCINOGENESIS$0
P01 · FY2001 · CA
CORE--TUMOR BIOLOGY$252,885
P01 · FY2000 · CA